Where can I get it legally?
Through a licensed 503A pharmacy filling a valid prescription documenting clinical justification.
Do I need a prescription?
Yes, required by federal law.
What is an individualized clinical reason?
Documented determination that commercial product cannot meet patient's specific clinical needs.
Can my regular doctor prescribe it?
Yes, if licensed and willing to document the clinical reason.
What does it cost in 2026?
Typically $250-$500/month for compounded; $349-$699/month for self-pay brand through LillyDirect.
Is buying compounded tirzepatide online safe?
Depends on whether the source is a licensed 503A pharmacy with verifiable credentials.
How long can I stay on compounded?
As long as clinical justification is documented and continues to apply.
Will compounded tirzepatide be banned?
An outright ban would require Congressional action; no legislation pending.
Does FormBlends still offer it?
Yes, through 503A pharmacy partners with documented clinical justification.
Related guides
- Can You Still Get Compounded Semaglutide? The 2026 Reality
- Is Compounded Tirzepatide Still Available? Yes, Under Specific Conditions
- Where to Get the Cheapest Compounded Tirzepatide in 2026 (And What "Cheapest" Actually Means)
- Will Compounded Semaglutide Be Banned? Distinguishing Reality from Worry
- How to Access Affordable Tirzepatide in 2026: Brand vs Compounded Cost Breakdown
- Mounjaro Injection Price Equivalent: What You'll Actually Pay for Brand vs Compounded Tirzepatide in 2026
Sources
- FDA Drug Shortage List update, October 2, 2024, resolving tirzepatide shortage
- Federal Food, Drug, and Cosmetic Act Section 503A, 21 U.S.C. § 353a
- USP General Chapter 797, Pharmaceutical Compounding - Sterile Preparations
- Outsourcing Facilities Association v. FDA, Northern District of Texas ruling, March 5, 2025
- Jastreboff AM et al., "Tirzepatide Once Weekly for the Treatment of Obesity," NEJM, July 2022 (SURMOUNT-1)
- Eli Lilly LillyDirect platform pricing and product information
- FDA Guidance, "Compounding and the FDA: Questions and Answers"
- National Association of Boards of Pharmacy compounding standards
- State Board of Pharmacy licensure verification databases (50 states)
- Zepbound FDA prescribing information, November 2023 with updates
- Mounjaro FDA prescribing information, May 2022 with updates
Footer disclaimers
Platform Disclaimer. FormBlends is a telehealth platform that connects patients with licensed clinicians and 503A compounding pharmacies. We do not practice medicine, dispense, or manufacture. Prescribing and compounding decisions are made by licensed professionals.
Get compounded tirzepatide, first month $149, then $239 per month, or $214 per month with Subscribe & Save
Free provider review, personalized dosing, and ongoing support included.
Start Free Assessment →Compounded Medication Notice. Compounded tirzepatide is prepared by licensed 503A pharmacy partners for individual patients based on prescriber-documented clinical reasons. The product is not FDA-approved and is not regulatorily equivalent to brand Mounjaro or Zepbound. SURMOUNT trial data applies to brand product specifically.
Results Disclaimer. Individual response varies significantly. SURMOUNT-1 reported a 22.5% mean weight loss at 15 mg over 72 weeks in a controlled trial; your real-world result will differ based on dose, adherence, baseline weight, and individual physiology.
Trademark Notice. Mounjaro, Zepbound, SURMOUNT, and LillyDirect are trademarks or service marks of Eli Lilly and Company. FormBlends is independent and not affiliated with Eli Lilly.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →